Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Thrombotic risk correlates with mutational status in true essential thrombocythemia.

European journal of clinical investigation - 1 Aug 2016

Bertozzi Irene, Peroni Edoardo, Coltro Giacomo, Bogoni Giulia, Cosi Elisabetta, Santarossa Claudia, Fabris Fabrizio, Randi Maria L

Abstract excerpt

BACKGROUND: True essential thrombocythemia (ET) may carry one of the known driver mutations (JAK2, MPL and CALR) or none of them [in triple-negative (3NEG) cases]. The patients' mutational status seems to delineate the clinical manifestations of ET. MATERIALS AND METHODS: We report the data of 183 patients diagnosed with ET strictly according to the WHO 2008 criteria and with a full molecular diagnosis, including...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Calreticulin
Share to Genetic Markers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Janus Kinase 2

Share to Leukocyte Count

Share to Platelet Count

Share to Receptors, Thrombopoietin

Share to Thrombocythemia, Essential

Share to Thrombosis

Source

Identifiers

PMID: 27271054
DOI: 10.1111/eci.12647

Genes

CALR
JAK2
MPL

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Thrombotic risk correlates with mutational status in true essential thrombocythemia.PMID 27271054Read ↗

The risk of thrombosis in essential thrombocythemia is associated with the type of CALR mutation: A multicentre collaborative study.Semantic proximity Read ↗

Analysis of CALR-mutated essential thrombocythemia as a distinct disease entity compared with JAK2 V617F-mutated and triple-negative patients.Semantic proximity Read ↗

Mutations and thrombosis in essential thrombocythemia: prognostic interaction with age and thrombosis history.Semantic proximity Read ↗

JAK2 V617F, MPL, and CALR mutations in essential thrombocythaemia and major thrombotic complications: a single-institute retrospective analysis.Semantic proximity Read ↗

Estimation of diagnosis and prognosis in ET by assessment of CALR and JAK2V617F mutations and laboratory findings: a meta-analysis.Semantic proximity Read ↗

Comparative thrombotic risk associated with CALR1 , CALR2 , and JAK2 V617F mutations in essential thrombocythemiaSemantic proximity Read ↗

Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.Semantic proximity Read ↗

[Gene mutation spectrum and clinical characteristics analysis of 178 patients with essential thrombocytosis].Semantic proximity Read ↗

The impact of JAK2V617F mutation on different types of thrombosis risk in patients with essential thrombocythemia: a meta-analysis.Semantic proximity Read ↗

Microparticle phenotypes are associated with driver mutations and distinct thrombotic risks in essential thrombocythemiaSemantic proximity Read ↗

Assessing the thrombotic risk of patients with essential thrombocythemia in the genomic era.Semantic proximity Read ↗

Mutations and long-term outcome of 217 young patients with essential thrombocythemia or early primary myelofibrosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.